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Neutron beams for therapy always contain some 'Y ray contamination that varies with depth 
and with distance from the beam axis. The problem therefore arises how the varying 'Y ray 
contribution should be accounted for in dose specification. Not infrequently a "total effective 
dose" DE is quoted that is equal to the neutron dose plus the 'Y ray dose divided by a 
constant weight factor T. On general biophysical considerations this appears to be not a valid 
approach since it must be assumed that T decreases with increasing dose. The nature and the 
magnitude of this dose dependence is derived in the present article. Application of the results 
to actual doses per fraction and to factual 'Y ray to neutron ratios demonstrates that the dose 
dependence of T has, in fact, very minor influence on the numerical values of DE • Utilization 
of a constant value T is therefore satisfactory in practice. 
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INTRODUCTION 
The specification of absorbed dose in a patient subjected to 
radiation therapy requires data on the spatial distribution of 
absorbed dose, but must also include information on radiation 
quality and its spatial variations. I A complete specification 
would have to be given in terms of the spectral distributions 
of fluence in particle type and particle energy in all points 
within the irradiated volume. For neutron beams this can be 
particularly important, as there may be substantial differ-
ences in radiation quality at different distances from the 
beam axis.2 However, in practice, it will frequently be im-
possible to achieve a complete description and a simplified 
treatment is therefore not uncommon. In a first approxima-
tion the change of radiation quality can be characterized by 
the varying ratio of neutron to )'-ray dose, and quoting the 
two doses separately can therefore be a satisfactory proce-
dure. Frequently one may wish to go even one step further 
and specify a neutron dose that is equivalent to the combi-
nation of the actual neutron and )'-ray doses. The problem 
then arises whether it is acceptable to use a constant weight 
factor for the )'-ray component or whether it is essential to 
applya variable factor that depends on the magnitude of the 
neutron and the )'-ray doses. This problem will be consid-
ered. 
COMBINED EFFECT OF THE NEUTRON AND 
GAMMA DOSE 
The need for the computation of an effective dose per 
fraction arises mainly in the consideration of effects on the 
normal tissue where tolerance levels are commonly related 
to a single quantity. An example of such a quantity is the 
nominal dose, computed by the Ellis-formula or its modifi-
cation for neutron irradiation.3 The derivation of this or 
similar quantities requires the statement of effective doses 
per fraction rat her than the separate specification of a neu-
tron and a )'-ray dose. The following considerations will 
therefore refer to normal tissue rather than to the tumor. This 
simplifies the discussion because the complicating aspect of 
hypoxic cells and of reoxygenation need not be taken into 
account. Instead the analysis can be linked to a consideration 
of survival curves. Survival curves of mammalian cells can 
be represented by various equations. Among these the lin-
ear-quadratic equation for the logarithm of the survival S 
- In S = aD + (bD)2 (I) 
is of the simplest form and it has the advantage that it permits 
a straightforward biophysical interpretation.4 In this inter-
pretation the linear term corresponds to a one-particle effect. 
The quadratic term (bD)2 corresponds to a two-particle ef-
fect. As the coefficients a and b depend, among other factors 
on radiation quality, one has different survival relations for 
neutrons and for )' rays: 
- In SN = aNDN + (bNDN)2 
- In SG = aGDG + (bGDG )2. (2) 
The indices N and G refer to neutrons and to )' rays. Ac-
cording to the biophysical interpretation4 the logarithmic 
reduction of cell survival probability, -ln S. is proportional 
to the yield of lesions. The linear terms in absorbed dose 
represent lesions that are formed in individual particle 
tracks. These linear terms are therefore simply additive for 
neutrons and )' rays. The quadratic terms represent the 
pairwise interaction of sublesions that are formed by separate 
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particles; they are therefore proportional to the square of the 
yield of sublesions. It follows that the yield of sublesions is 
for ')' rays proportional to bcDc and for neutrons to bNDN. 
Accordingly the quadratic term for the mixed field is the 
square of the term (bcDc + bNDN) that represents the yield 
of sublesions. One obtains consequently the following relation 
for a ')'-ray dose Dc and a neutron dose DN applied in one 
session: 
- In SN+C = aNDN + acDc + (bNDN + bc Dc )2 
= aNDN + acDc + (bNDN)2 + (bcDc)2 
+ 2bNbcDNDC. (3) 
Zaider and Rossi5 give a more detailed discussion of this 
survival equation under a mixed irradiation. It should be 
pointed out that the linear-quadratic relation may be merely 
an approximation that is in reasonable agreement with ex-
perimental da ta without being rigorously valid. It can nev-
ertheless be utilized, since the present analysis aims not at 
a precise formulation but at a rough assessment of the nature 
of the dose dependence for the weight factor 7. 
DETERMINATION OF THE WEIGHT FACTOR 
Equation (3) can be used to compute the neutron dose DE 
that has an effect equal to that of the actual neutron and the 
')'-ray dose combined. This dose, DE • will be called the total 
effective dose (the notation employed in this article follows 
the conventions proposed by ECNEU (European Clinical 
Neutron Dosimetry Group) in the fourth draft of a European 
Protocol for Neutron Dosimetry for External Beam Therapy 
(August 1979). DN: absorbed dose of neutrons; Da: absorbed 
dose of ')' rays; DT : total absorbed dose; DE = total effective 
dose = DN + Da /7) of a neutron beam contaminated by ')' 
rays. The weight factor for the neutron relative to the ')'-ray 
dose in the computation of the equivalent neutron dose DE 
will be designated by 7: 
(4) 
From the condition: 
aNDE + b;'D'i = aNDN + acDc + bfvDfv 
+ bbDb + 2 bNbcDNDC (5) 
one obtains: 
aNDN + aNDc/7 + bfvDfv + 2bF.DNDC/7 + bfvDb!7 2 
= aNDN + acDc + bfvD;' + bbDb + 2bNbcDNDC (6) 
and: 
72(ac + bbDc + 2bNbcDN) 
- 7(aN + 2bfvDN) - bfvDc = 0; (7) 
therefore: 
with: 
CI = ac + bbpDT + 2bNbC(1 - p )DT 
C2 = aN + 2bfv(1 - p )DT 
C3 = bfvpDT• 
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FIG. I. RBE of neutrons versus 'Y rays for the linear-quadratic relation [Eq 
(2) land the parameters bN = bG = 0.16 Gy-I, aG = 0.13 Gy-I, and aN/aG 
= 6,4, or 3 (solid lines). The broken line corresponds to a curve derived by 
Field (1) for d(l5)Be-neutrons and various effects on the skin; the dotted 
line corresponds to a curve given by Field (I) for acute effects on the intes-
tine. 
where DT is the total absorbed dose: 
DT= DN +Dc. 
and p the relative')' ray contribution: 
p = Dc/DT. 
(10) 
(Il) 
The formula for 7 appears somewhat complicated, but it is 
readily evaluated. It will be noted that at small doses the value 
7 converges towards aN/aC. while for large doses it tends 
towards bN/bc . If the ')'-ray dose is small compared to the 
neutron dose (p « 1) one obtains the simpler relation: 
7~ 
aN + 2b;'DT 
ac + 2bNbcDT 
(12) 
NUMERICAL EVALUATION AND DISCUSSION 
Ha1l6,7 has recently performed extensive intercomparisons 
of survival curves of V -79 hamster cells exposed to neutron 
beams at various therapy installations. The experiments in-
clude also repeated control experiments with ')' rays. 
The ')'-ray survival curves can be represented by the pa-
rameters ac = 0.13 Gy-I and bc = 0.16 Gy-I. The neutron 
survival curves do not permit the derivation of precise values 
of bN . The results of earlier experiments8,9 are also somewhat 
uncertain with regard to bN . At neutron energies below 1 
MeV there is evidence that bN exceeds bc; for larger energies, 
as applied in therapy, any difference between bN and bc 
appears to bt smalI. Results will therefore first be derived for 
an assumed equality of the coefficients bN and bc; subse-
quently, larger va lues for bN will be considered and it will be 
seen that the dependence of 7 on dose will then be less im-
portant than for equal values bN and bc . 
Estimated values of aN vary from aN = 0.46 Gy-I for a 
neutron beam produced by d(50) + Be neutrons (Tamvec) 
to aN = 0.66 Gy-I for d(15) + Be neutrons (Hammersmith). 
The ratios aN/aC are therefore contained within a range of 
values from roughly 3-6, and the dependence of RBE on the 
total dose DT that corresponds to the values 3, 4, and 6 is 
plotted in Fig. 1. A comparison to in vivo da ta indicates 
substantial agreement with this dependence between RBE 
and dose. Field3 has compiled results from various authors 
for the RBE of d(15) + Be neutrons for skin damage. In Fig. 
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FIG.2. Weight factor T as a function of total dose DT. p is the ratio ofthe 
")I-ray dose to the total dose. The three curves belong (beginning from the 
lowest curve) to the va lues p = 0.1,0,5, and 0.9. The parameters [see Eq. 
(2») are bN = bc = 0.16 Gy-I and ac = 0,13 Gy-I, The panels belong to 
the ratios aN/aC = 5,4, and 3. 
1 his relation for the RBE as a function of neutron dose per 
fraction is replotted (broken line). A second curve (dotted 
line) is areplot of the curve given by Field for acute intestinal 
damage. Apart from possible differences at small doses, there 
is reasonable agreement between the in vitro and in vivo re-
sults, as far as the characteristic dependence of RBE on dose 
is concerned. This supports the utilization of the in vitro data, 
i.e., of the survival curve parameters. Accordingly the factor 
T is calculated with the values ae = 0.13 Gy-l and b = bN 
= be = 0.16 Gy-l and with various ratios of the neutron 
RBE at low doses, aN/aC. 
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FIG.4, Weight factor T as a function of total dose DT . pis the ratio ofthe 
")I-ray dose to the total dose. The three curves belong (beginning from the 
lowest curve) to the values p =0,1,0,5, and 0.9, The parameters [see Eq. 
(2») are bN = 2bc; bc = 0,16 Gy-I; aN/ac = 4, and ac = 0.13 Gy-I. 
This will make it possible to derive the dependence of Ton 
dose. The nature of this dependence will not critically depend 
on the exact values of ae and b; the results are therefore 
meaningful even if the application of da ta from cell culture 
experiments to the reaction of the irradiated tissue is 
doubtful. The results are given in Fig. 2. The different panels 
refer to the values 3, 4, and 5 of the ratio aN/aC. In each 
graph curves are given for p = 0.1,0.5, and 0.9. The values 
for p = 0.1 are nearly identical to the values for p ~ 0 that 
result from Eq. (12). 
At doses DT of 1-2 Gy the graph for aN/aC = 4 agrees weil 
with the value of T = 3 that is presently used at most neutron 
therapy centers for d( 15) + Be neutrons. It provides therefore 
the dependence ofvalues T on total dose that can be compared 
to the use of a fixed value T. 
Table 1 exemplifies the differences in numerical values for 
the effective dose DE that result from the use of fixed and 
variable values T. The ratios of the 'Y ray to neutron dose for 
two depths at the isocentric neutron therapy facility CIRCE 
in Essen (see Fig. 3) are used in the comparison. Two current 
fractionation schemes (HammersmithlO,ll, and Essen I2,13) 
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FIG. 3. Dependence of the total absorbed 
dose DT and the ")I-ray dose on depth along 
the axis of the beam in a water phantom. The 
curves refer to the beam of d(I4)Be-neu-
trons (14 MeV deuterons on thick Berylli-
um) of the cyclotron therapy facility CIRCE 
at Essen, Dr/DT.ma.: ratio of total absorbed 
dose to its maximum value. DclDT = p: 
ratio of ")I-ray dose to total dose. DG/DT.ma.: 
ratio of ")I-ray dose to maximum total 
dose. 
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TADLE 1. Practical consequences of using variable weight factors T for 
d(14) + Be neutrons (mean energy 5.5 MeV) of the cyclotron neutron 
therapy facility CIRCE in Essen, Field size 20 cm X 20 cm; source-sur-
face-distance 125 cm; water phantom. 
Parameters for single fraction 
DN/Gy 
Da/Gy 
DT/Gy 
p = Da/DT 
DT(zd/DT(zo) 
Commonly used constant 
weight factor 
T 
DE/Gy 
D5 (ZI)/DE(ZO) 
Variable weight factor T for 
aN/aG = 0.52/0.13 = 4 
according Fig. 2 
T (approx. Eq. 12) 
T (Eq. 8,9) 
DE/Gy 
DE(zd/DE(ZO) 
Variable weight factor T for 
aN/aG = 0.66/0.13 '" 5 
according Fig. 2 
T [approx. Eq. (12)] 
T Eqs. (8), (9) 
DE/Gy 
DE(zd/DE(ZO) 
Fractionation Fractionation 
Hammersmith Essen 
Phantom depth 
ZO = 5 Zl = 20 Zo = 5 ZI = 20 
cm cm cm cm 
11.3001 0.271 0.772 0.161 
0.144 0.074 0.086 0.044 
1.444 0.345 0.856 0.205 
0.100 0.214 0.100 0.214 
0.239 0.239 
3.00 3.00 3.00 3.00 
1.348 0.296 10.8001 0.176 
0.220 0.220 
2.91 3.64 3.24 3.78 
2.94 3.67 3.27 3.80 
1.349 0.291 0.798 0.173 
0.216 0.217 
3.60 4.59 4.05 4.77 
3.63 4.63 4.08 4.80 
1.340 0.287 0.793 0.170 
0.214 0.215 
are considered. (The fr action at ion on the basis of total ef-
fective dose, DE. has been agreed upon by three members 
(Amsterdam, Edinburgh, Essen) of the EORTC Project 
Group on Neutron and Fast Particle Therapy.) 
The computations are performed according to Eqs. 8 and 
9 or the approximation of Eq. 12 with the parameters aG = 
0.13 Gy-I, bG = bN = 0.16 Gy-I, and the value aN = 0.52 
Gy-I that agrees with the ratio aN/aG = 4 (intermediate 
panel in Fig. 2). The results are given in the penultimate row 
of boxes in Table 1. At the bottom of Table 1 numerical re-
sults are given for the value aN = 0.66 Gy-I that corresponds 
to the lower panel of Fig. 2 and that is indicated by the cell 
culture experiments of Ha1l6,7 with the d(15) + Be neutrons 
of Hammersmith. 
The essential result is that there is, indeed, a pronounced 
dependence of the weight factor T on total dose DT . This 
applies for both sets of parameters that are considered. 
However, neither the absolute uncertainty of T nor its de-
pendence on DT have substantial influence on the magnitude 
of the resulting effective dose DE . The use of a fixed weight 
factor T is therefore still justified in clinical applications. 
It remains to examine the possibility that the coefficient 
of the quadratic term in absorbed dose is larger for neutrons 
Medleal Physles, Vol. 7, No. 5, Sept.lOel. 1980 
than for I' rays. For this purpose the weight factor T is derived 
für aN/aG = 4 as in Fig. 2, but with bN/bG = 2. The results 
are given in Fig. 4. As expected, the dependence of T on total 
dose is less pronounced in this case. This implies that the use 
of a constant weight factor T leads to even smaller impreci-
sions if bN exceeds bG. 
CONCLUSION 
In agreement with experimental observations and with 
general biophysical considerations, the RBE of neutrons 
relative to 1'. rays is largest at smallest doses. It follows that 
the factor T, that weights the neutron absorbed dose relative 
to the I' ray absorbed dose, decreases with increasing dose 
per fraction. From the linear-quadratic dependence of the 
logarithm of cellular survival and from parameters of survival 
curves, a numerical dependence of T on total dose can be 
obtained. 
Although the dependence of T on dose is pronounced, it 
plays only a very minor role in actual numerical evaluations. 
It is consequently acceptable to apply a fixed weight factor 
T in order to correct for the 'Y-ray component in a neutron 
beam. In the present analysis parameters from cell survival 
curves are used as input data to obtain general guidance on 
the magnitude of the numerical values in the equations. 
However, it is evident that appropriate values of T must be 
based on radiobiological investigations and clinical trials with 
a particular neutron beam. 
The general conclusion of this investigation will not be 
applicable to a mixed modality treatment where substantial 
I' ray and neutron doses are given in one session. Only in such 
cases would the dose dependence of T have to be taken into 
account. 
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